Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 7-day randomized, double-blind, placebo-controlled exploratory study

This 7-day randomized, double-blind, placebo-controlled fixed-dose study (NCT03766867) explored the potential for accelerating the onset of antidepressant efficacy of single-dose intravenous (IV) vortioxetine at oral vortioxetine treatment initiation. Patients (ages 18–65 years) hospitalized per sta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int Clin Psychopharmacol
Main Authors: Rancans, Elmars, Zambori, Janos, Dalsgaard, Mads, Baayen, Corine, Areberg, Johan, Ettrup, Anders, Florea, Ioana
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams And Wilkins 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7531504/
https://ncbi.nlm.nih.gov/pubmed/32784346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000326
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados